title: POINT: Will New Anti-eosinophilic Drugs Be Useful in Asthma Management? Yes.
authors.affiliation: Firestone Institute of Respiratory Health and the Department of Medicine, Michael G. DeGroote School of Medicine, McMaster University, Hamilton, ON, Canada. Electronic address: obyrnep@mcmaster.ca.
authors.forename: Paul M
authors.initials: PM
authors.lastname: O'Byrne
mesh_terms: D001249:Asthma / Q000097:blood / Q000188:drug therapy / Q000276:immunology; D001685:Biological Factors / Q000494:pharmacology*; D001691:Biological Therapy / Q000379:methods; D004351:Drug Resistance; D004804:Eosinophils / Q000187:drug effects*; D006801:Humans; D015848:Interleukin-5 / Q000037:antagonists & inhibitors / Q000276:immunology; D008213:Lymphocyte Activation / Q000187:drug effects*; D018375:Neutrophil Activation / Q000187:drug effects*; D010346:Patient Care Management / Q000639:trends; D016896:Treatment Outcome
chemical_list: D001685:Biological Factors; D015848:Interleukin-5